Therapeutic Outcome of Extranodal NK/T-Cell Lymphoma Initially Treated with Chemotherapy
Result of Chemotherapy in NK/T-Cell Lymphoma

References

• Jaffe ES. Nasal and nasal-type T/NK cell lymphoma: a unique form of lymphoma associated with the Epstein-Barr virus. Histopathology 1995; 27: 581–31.
   PubMed Web of Science ®Google Scholar
• Ko YH, Kim CW, Park CS, et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lym-phoma. Cancer 1998; 83: 806–12.
   Google Scholar
• Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–92.
   PubMed Web of Science ®Google Scholar
• Jaffe ES, Chan JK, Su IJ, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epi-demiology. Am J Surg Pathol 1996; 20: 103–11.
   Google Scholar
• Harris NL, Jaffe ES, Diebold J, et al. World Health Organiza-tion classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Commit-tee Meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–49.
   PubMed Web of Science ®Google Scholar
• Chan JK, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopatho-logic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997; 89: 4501–13.
   PubMed Web of Science ®Google Scholar
• Girinsky T, Domenge C, Bosp J, et al. Early locoregional radiotherapy is associated with long-term disease-control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia 2001; 15: 1123–6.
   PubMedGoogle Scholar
• Chen HH, Fong L, Su IJ, et al. Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: a retrospective analysis covering a 34-year period. Radiother Oncol 1996; 38: 1–6.
   PubMed Web of Science ®Google Scholar
• Sobrevilla-Calvo P, Meneses A, Alfaro P. Radiotherapy com-pared to chemotherapy as initial treatment of angiocentric centrofacial lymphoma (polymorphic reticulosis). Acta Oncol 1993; 32: 69–72.
   Google Scholar
• Aviles A, Rodriguez L, Guzman R, et al. Angiocentric lymphoma of the nose, paranasal sinus and hard palate. Hematol Oncol 1992; 10: 141–7.
   PubMedGoogle Scholar
• Logsdon MD, Ha CS, Kavadi VS, et al. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. Cancer 1997; 80: 477–88.
   PubMed Web of Science ®Google Scholar
• Kim GE, Cho JH, Yang WI, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol 2000; 18: 54–63.
   PubMed Web of Science ®Google Scholar
• Kwong YL, Chan AC, Liang R, et al. CD56 + NK lymphomas: clinicopathological features and prognosis. Br J Haematol 1997; 97: 821–9.
   PubMed Web of Science ®Google Scholar
• Liang R, Todd D, Chan TK, et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol 1995; 13: 666–70.
   PubMed Web of Science ®Google Scholar
• Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype and treatment outcome in 113 patients. J Clin Oncol 1998; 16: 70–7.
   PubMed Web of Science ®Google Scholar
• Drenou B, Lamy T, Amiot L, et al. CD3 — CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance. Blood 1997; 89: 2966–74.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Kita K, Miwa H, et al. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer 1995; 76: 2351–6.
   PubMed Web of Science ®Google Scholar
• Li YX, Coucke PA, Li JY, et al. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and che-motherapy. Cancer 1998; 83: 449–56.
   PubMed Web of Science ®Google Scholar
• Aviles A, Diaz NR, Neri N, et al. Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients. Clin Lab Haematol 2000; 22: 215–20.
   PubMedGoogle Scholar
• Reyes F, Lepage E, Munck JN, et al. Superiority of chemother-apy alone with the ACVBP regimen over treatment with three cycles of CHOP plus radiotherapy in low risk localized aggressive lymphoma: the LNH93-1 GELA Study. Proc Am Soc Hematol 2002; Abstr 343.
   Google Scholar
• Fillet G, Bonnet C, Mounier N, et al. Radiotherapy is unnecessary in elderly patients with localized aggressive non Hodgkin's lymphoma: results of the GELA LNH 93–4 study. Proc Am Soc Hematol 2002; Abstr 337.
   Google Scholar
• Miller TP, Leblanc M, Spier C, et al. CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non—Hodgkin's lymphomas: update of the Southwest Oncology Group (SWOG) randomized trial. Proc Am Soc Hematol 2001; Abstr 3024.
   Google Scholar